Changes in corneal thickness in patients with treated and untreated ocular hypertension

Cornea

Volumn 25, Issue 6, 2006, Pages 639-643

  Herman, David C ^a   Hodge, David O ^a   Bourne, William M ^a  

^a MAYO CLINIC   (United States)

Author keywords

Corneal drug effects; Corneal epithelial thickness; Corneal thickness; Ocular hypertension

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; PROSTAGLANDIN DERIVATIVE;

ARTICLE; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORNEA THICKNESS; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; PRIORITY JOURNAL;

ANTIHYPERTENSIVE AGENTS; CORNEA; FOLLOW-UP STUDIES; HUMANS; INTRAOCULAR PRESSURE; MICROSCOPY, CONFOCAL; OCULAR HYPERTENSION; TONOMETRY, OCULAR;

EID: 33750542175     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000214231.28862.03     Document Type: Article

References (35)

1. Korey M, Gieser D, Kass MA, et al. Central corneal endothelial cell density and central corneal thickness in ocular hypertension and primary open-angle glaucoma. Am J Ophthalmol. 1982;94:610-616.
2. Argus WA. Ocular hypertension and central corneal thickness. Ophthalmology. 1995;102:1810-1812.
3. Herndon LW, Choudhri SA, Cox T, et al. Central corneal thickness in normal, glaucomatous, and ocular hypertensive eyes. Arch Ophthalmol. 1997;115:1137-1141.
4. Wolfs RCW, Klaver CCW, Vingerling JR, et al. Distribution of central corneal thickness and its association with intraocular pressure: The Rotterdam study. Am J Ophthalmol. 1997;123:767-772.
5. Copt R-P, Thomas R, Mermoud A. Corneal thickness in ocular hypertension, primary open-angle glaucoma, and normal tension glaucoma. Arch Ophthalmol. 1999;117:14-16.
6. Herman DC, Hodge DO, Bourne WM. Increased corneal thickness in patients with ocular hypertension. Arch Ophthalmol. 2001;119:334-336.
7. Varma R, Ying-Lai M, Francis BA, et al. Prevalence of open-angle glaucoma and ocular hypertension in Latinos. The Los Angeles Latino eye study. Ophthalmology. 2004;111:1439-1448.
8. Ehlers N, Bramsen T, Sperling S. Applanation tonometry and central corneal thickness. Acta Ophthalmol (Copenh). 1975;53:34-43.
9. Whitacre MM, Stein RA, Hassanein K. The effect of corneal thickness on applanation tonometry. Am J Ophthalmol. 1993;115:592-596.
10. Brubaker RF. Tonometry and corneal thickness. Arch Ophthalmol. 1999;117:104-105.
11. Doughty MJ, Zaman ML. Human corneal thickness and its impact on intraocular pressure measures: A review and meta-analysis approach. Surv Ophthalmol. 2000;44:367-408.
12. Ytteborg J, Dohlman C. Corneal edema and intraocular pressure. I. Animal experiments. Arch Ophthalmol. 1965;74:375-381.
13. Ehlers N. The fibrillary texture and the hydration of the cornea. Acta Ophthalmol Scand. 1966;44:620-630.
14. Ehlers N. On corneal thickness and intraocular pressure. II. A clinical study on the thickness of the corneal stroma in glaucomatous eyes. Acta Ophthalmol (Copenh). 1970;48:1107-1112.
15. Mayes KR, Hodson S. Some effects of hydrostatic pressure on corneal hydration during specular microscopy. Exp Eye Res. 1978;26:141-145.
16. McPhee TJ, Bourne WM, Brubaker RF. Location of the stress-bearing layers of the cornea. Invest Ophthalmol Vis Sci. 1985;26:869-872.
17. Ytteborg J, Dohlman CH. Corneal edema and intraocular pressure. II. Clinical results. Arch Ophthalmol. 1965;74:477-484.
18. Ehlers N, Riise D. On corneal thickness and intraocular pressure. Acta Ophthalmol (Copenh). 1967;45:809-813.
19. Gordon MO, Kass MA. For the Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study. Design and baseline description of the participants. Arch Ophthalmol. 1999;117:573-583.
20. Winter EJ, Herman DC, Hodge DO, et al. Endothelial cell density in the ocular hypertension treatment study (OHTS): single-center results. Invest Ophthalmol Vis Sci. 2003; ARVO E-Abstract 4721; http://www.arvo.org.
21. Nau CB, Herman DC, Hodge DO, et al. Corneal stromal cell density in treated vs. non-treated patients of the ocular hypertension treatment study: single center evaluation. Invest Ophthalmol Vis Sci. 2004; ARVO E-Abstract 3829; http://www.arvo.org.
22. Patel SV, McLaren JW, Hodge DO, et al. Normal human keratocyte density and corneal thickness measurement by using confocal microscopy in vivo. Invest Ophthalmol Vis Sci. 2001;42:333-339.
23. McLaren JW, Nau CB, Erie JC, et al. Corneal thickness measurement by confocal microscopy, ultrasound, and scanning slit methods. Am J Ophthalmol. 2004;137:1011-1020.
24. Kass MA, Heuer DK, Higginbotham EJ, et al. The ocular hypertension treatment study. A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary openangle glaucoma. Arch Ophthalmol. 2002;120:701-713.
25. Lass JH, Eriksson GL, Osterling L, et al. Comparison of the corneal effects of latanoprost, fixed combination latanoprost-timolol, and timolol. A double-masked, randomized, one-year study. Ophthalmology. 2001;108:264-271.
26. Lass JH, Khosrof SA, Laurence JK, et al. A double-masked, randomized, 1-year study comparing the corneal effects of dorzolamide, timolol and betaxolol. Arch Ophthalmol. 1998;116:1003-1010.
27. Hahn S, Azen S, Ying-Lai M, et al. Central corneal thickness in Latinos. Invest Ophthalmol Vis Sci. 2003;44:1508-1512.
28. Shimazaki J, Hanada K, Yagi Y, et al. Changes in ocular surface caused by antiglaucomatous eyedrops: prospective, randomised study for the comparison of 0.5% timolol v 0.12% unoprostone. Br J Ophthalmol. 2000;84:1250-1254.
29. Niiya A, Yokoi N, Matsumoto Y, et al. Effect of beta-blocker eyedrops on corneal epithelial function. Ophthalmologica. 2000;214:332-336.
30. Ishibashi T, Yokoi N, Mori K, et al. Influence of latanoprost on the corneal epithelial barrier function in glaucoma patients. Ophthalmologica. 2002;216:351-354.
31. Erie JC, Patel SV, McLaren JW, et al. Effect of myopic laser in situ keratomileusis on epithelial and stromal thickness. A confocal microscopy study. Ophthalmology. 2002;109:1447-1452.
32. Huang PT, Nelson LR, Bourne WM. The morphology and function of healing cat corneal endothelium. Invest Ophthalmol Vis Sci. 1989;30:1794-1801.
33. Brandt JD, Beiser JA, Kass MA, et al. Central corneal thickness in the ocular hypertension treatment study (OHTS). Ophthalmology. 2001;108:1779-1788.
34. Gordon MA, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study. Baseline factors that predict the onset of primary openangle glaucoma. Arch Ophthalmol. 2002;120:714-720.
35. Palmberg P. Answers from the ocular hypertension treatment study. Arch Ophthalmol. 2002;120:829-830.